Inhibikase Therapeutics, Inc. IKT
2.06
(0.04)
(1.90%)
as of 25 Sep
- Market cap
- $293.0M
- P/E
- 0.0×
Follow IKT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
11.55 | 21.54 | 29.83 | 15.50 | |
Current Ratio |
11.73 | 21.70 | 30.14 | 15.82 | |
Net Debt/EBITDA |
6.07 | 12.98 | 9.55 | 7.55 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.59 | 0.74 | 0.64 | |
Capex/Depreciation |
0.00 | 0.00 | — | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.12) | (0.08) | (0.07) | (0.07) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.12) | (0.08) | (0.07) | (0.07) | |
Cash per Share |
0.86 | 1.82 | 0.99 | 0.91 | |
Shareholders Equity per Share |
0.81 | 1.76 | 0.97 | 0.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.81 | 1.76 | 0.97 | 0.88 | |
Free Cash Flow |
(10.59) | (7.52) | (12.06) | (12.44) | |
Working Capital |
71.84 | 171.81 | 166.46 | 152.08 | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
71.84 | 171.81 | 166.46 | 152.08 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.57 | 1.05 | 1.64 | 1.85 | |
Average Assets |
41.99 | 139.90 | 133.81 | 126.22 | |
Average Common Equity |
36.18 | 133.89 | 126.68 | 116.69 |
Columns are period end dates